<DOC>
	<DOCNO>NCT02795780</DOCNO>
	<brief_summary>This study evaluate longitudinal change tau deposition measure 18F-AV-1451 uptake time .</brief_summary>
	<brief_title>Follow 18F-AV-1451 Scan Confirmatory Cohort Subjects From Study 18F-AV-1451-A05</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Confirmatory cohort subject complete 18FAV1451A05 ( NCT02016560 ) study Current clinically significant cardiovascular disease , ECG abnormality , risk factor Torsades de Pointes ( TdP ) , take drug know cause QT prolongation Current clinically significant infectious disease , endocrine metabolic disease , pulmonary , renal hepatic impairment , cancer Females childbearing potential surgically sterile , refrain sexual activity use reliable method contraception Have nonstudy related radiopharmaceutical imaging treatment procedure within 7 day prior study image session Have receive participated trial investigational medication past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>